EP0161816A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Urogastrone
Assignee: Imperial Chemical Industries Ltd
•
Filing: 1985-04-16
•
Granted: —
•
Expires: 2005-04-16
Abstract
Abstract Pharmaceutical compositions comprise human urogastrone or a urogastrone fragment in combination with a known anti-ulcer agent as active ingredient and such active ingredients may be used for the manufacture of a medicament for promoting healing of gastrointestinal ulcers.
Inventors
- 👤 Harold Gregory
- 👤 Keith Graham Mccullagh
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-03 11:33
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1808; A61P; A61P1/00; A61P1/04
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
28 words
A pharmaceutical composition comprising (1) human urogastrone or a urogastrone fragment and (2) a known anti-ulcer agent as active ingredients in association with a pharmceutical carrier or excipient.
Claim 2
Dependent Claim
28 words
A pharmaceutical composition comprising (1) human urogastrone or a urogastrone fragment and (2) a known anti-ulcer agent as active ingredients in association with a pharmceutical carrier or excipient.
Claim 3
Dependent Claim
14 words
A composition as claimed in claim 1 in a form adapted for oral administration.
Claim 4
Dependent Claim
14 words
A composition as claimed in claim 1 or claim 2 in dosage unit form.
Claim 5
Dependent Claim
23 words
A composition as claimed in any one of the preceding claims which comprises human urogastrone and a known anti-ulcer agent as active ingredients.
Claim 6
Dependent Claim
31 words
The use of (1) human urogastrone or a urogastrone fragment and (2) a known anti-ulcer agent for the manufacture of a medicament for promoting the healing in mammals of gastrointestinal ulcers.
Claim 7
Dependent Claim
31 words
The use of (1) human urogastrone or a urogastrone fragment and (2) a known anti-ulcer agent for the manufacture of a medicament for promoting the healing in mammals of gastrointestinal ulcers.
Claim 8
Dependent Claim
29 words
The use of urogastrone or a urogastrone fragment and a known anti-ulcer agent as claimed in claim 5 wherein the medicament is for promoting the healing of duodenal ulcers.
Claim 9
Dependent Claim
32 words
The use of urogastrone or a urogastrone fragment and a known anti-ulcer agent as claimed in claim 5 or claim 6 wherein the medicament is in a form adapted for oral administration.
Claim 10
Dependent Claim
26 words
The use of urogastrone or a urogastrone fragment and a known anti-ulcer agent as claimed in claim 7 wherein the medicament is in dosage unit form.
Claim 11
Dependent Claim
36 words
For use in promoting the healing of gastrointestinal ulcers in mammals, a pharmaceutical composition adapted for oral administration which comprises as active ingredients (1) human urogastrone or a urogastrone fragment and (2) a known anti-ulcer agent.
Claim 12
Dependent Claim
36 words
For use in promoting the healing of gastrointestinal ulcers in mammals, a pharmaceutical composition adapted for oral administration which comprises as active ingredients (1) human urogastrone or a urogastrone fragment and (2) a known anti-ulcer agent.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.